Persisting cost inflation and pricing pressures impact pharma industry: ICRA https://ift.tt/6mIGgwH

Most major Indian pharmaceutical companies continue to focus on emerging markets to fuel their growth, given that they continue to face pricing pressure in the US and the European markets. The outlook for the Indian pharma industry remains stable, led by expectations of continued steady revenue growth and comfortable margins.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/6Q7VnJd